ArticleOrthopaedic journal of sports medicine2025
Debridement or Microfracture for Full-Thickness Cartilage Lesions in Anterior Cruciate Ligament Reconstruction: A 10-Year Cohort Study of 326 Patients in Norway and Sweden.
Article in Orthopaedic journal of sports medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: It is well-established that patients undergoing anterior cruciate ligament reconstruction (ACLR) have a less favorable prognosis if a concomitant full-thickness cartilage lesion is present at the time of surgery. However, the long-term benefits of surgically addressing these cartilage lesions remain uncertain. Purpose: To evaluate whether the most used surgical treatments for cartilage lesions influenced patient-reported outcomes 10 years after ACLR. Study Design: Cohort study; Level of evidence, 2. Methods: This study was based on a cohort of all patients with primary unilateral ACLR in the Norwegian and Swedish knee ligament registries from January 2005 through December 2008 (n = 15,783). A total of 1012 (6.4%) patients had ≥1 full-thickness cartilage lesion (International Cartilage Regeneration & Joint Preservation Society grade 3 or 4) at the time of reconstruction. Of these, 644 patients met the inclusion criteria. At a mean (± SD) follow-up of 10.1 ± 0.2 years, 326 (51%) of the patients had completed the Knee injury and Osteoarthritis Outcome Score (KOOS). The treatment categories documented in the Scandinavian knee ligament registries were microfracture, debridement, no treatment, or other/unknown. Patients who did not receive surgical treatment for their full-thickness cartilage lesions served as the reference group and were compared with those who underwent microfracture or debridement. Multiple linear regression, with adjustment for possible confounders, was used to evaluate associations between surgical treatment of cartilage lesions and patient-reported outcomes for all KOOS subscales 10 years after ACLR. Results: Of the 326 patients available at the 10-year follow-up, 182 (56%) had not received surgical treatment for their cartilage lesions. A total of 68 (21%) patients had been treated with debridement, and 76 (23%) patients had been treated with microfracture. No significant association with KOOS scores was observed for debridement or microfracture compared with the reference group without surgical treatment of their cartilage lesion. The unadjusted data showed a trend toward poorer outcomes with microfracture compared with debridement, but this difference was not statistically significant. Conclusion: Debridement and microfracture showed no significant association with patient-reported outcomes 10 years after ACLR in patients with concomitant full-thickness cartilage lesions, compared with those who did not receive surgical treatment for their cartilage lesion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.